AIDS and Behavior

, Volume 15, Issue 1, pp 209–213 | Cite as

Alcohol Consumption is Associated with Poor Health in HIV Clinic Patient Population: A Behavioral Surveillance Study

  • Enbal ShachamEmail author
  • Abayomi Agbebi
  • Kate Stamm
  • E. Turner Overton
Original Paper


Previous research reports that populations with HIV consume higher rates of alcohol than general population. This cross-sectional study (n = 391) was conducted to measure alcohol consumption, factors associated with consumption, and the relationship between alcohol and HIV viral loads among individuals receiving HIV care. Increased alcohol consumption was associated with being male, lower education attainment, and lacking a current HAART prescription. Additionally, among those currently on HAART, unsuppressed viremia was associated with higher levels of alcohol consumption. These findings suggest that there may be a relatively low level of alcohol consumption that is detrimental to virologic suppression among populations with HIV.


HIV Alcohol use Screening Viral load suppression 



This publication was partially supported by Grant Number UL1 RR024992 from the National Center for Research Resources (NCRR), specifically KL2RR024994. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. Dr. Overton has served as a consultant or on an advisory board for the following companies: Gilead, Bristol Myers Squibb, Glaxo-Smith-Kline, Tibotec, Merck, Monogram Sciences and Boehringer Ingelheim. He also has received research support from the following companies: Abbott, Gilead, Bavarian Nordic, Glaxo-Smith-Kline, Boehringer Ingelheim, and Tibotec.


  1. 1.
    Galvan FH, Bing EG, Fleishman JA, London AS, Caetano R, Burnam MA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV cost and services utilization study. J Stud Alcohol Drugs. 2002;63(2):179–86.Google Scholar
  2. 2.
    Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatr Clin North Am. 1999;22(2):241–52.CrossRefPubMedGoogle Scholar
  3. 3.
    Wilsnack RW, Vogeltanz ND, Wilsnack SC, Harris TR. Gender differences in alcohol consumption and adverse drinking consequences: cross-cultural patterns. Addiction. 2000;95(2):251–65.CrossRefPubMedGoogle Scholar
  4. 4.
    Lopez OL, Becker JT, Dew MA, Caldararo R. Risk modifiers for peripheral sensory neuropathy in HIV infection/AIDS. Eur J Neurol: Blackwell Publishing Limited; 2004. p. 97–102.Google Scholar
  5. 5.
    Cooper CL, Cameron DW. Effect of alcohol use and highly active antiretroviral therapy on plasma levels of Hepatitis C virus (HCV) in patients coinfected with HIV and HCV. Clin Infect Dis: Infect Dis Soc Am. 2005;41:S105–9.Google Scholar
  6. 6.
    Samet JH, Horton NJ, Traphagen ET, Lyon SM, Freedberg KA. Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res. 2003;27(5):862–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. JAIDS J Acquir Immune Defic Syndr. 2006;43(4):411–7.CrossRefGoogle Scholar
  8. 8.
    Braithwaite RS, McGinnis KA, Conigliaro J, Maisto SA, Crystal S, Day N, et al. A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res. 2005;29(7):1190–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Stein M, Herman DS, Trisvan E, Pirraglia P, Engler P, Anderson BJ. Alcohol use and sexual risk behavior among human immunodeficiency virus-positive persons. Alcohol Clin Exp Res. 2005;29(5):837–45.CrossRefPubMedGoogle Scholar
  10. 10.
    CDC. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the health resources and services administration, the national institutes of health, and the HIV medicine association of the infectious diseases society of America. Morbidity and mortality weekly report. 2003;52(RR-12).Google Scholar
  11. 11.
    Temoshok LR, Wald RL. Integrating multidimensional HIV prevention programs into healthcare settings. Psychosom Med. 2008;70(5):612–9.CrossRefPubMedGoogle Scholar
  12. 12.
    NIAAA. Helping patients who drink too much; 2007.Google Scholar
  13. 13.
    Kroenke K, Spitzer R, Williams J. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefPubMedGoogle Scholar
  14. 14.
    Shacham E, Nurutdinova D, Satyanarayana V, Stamm K, Overton ET. Routine screening for depression: identifying a challenge for successful HIV care. AIDS Patient Care STDs. 2009;23(11):949–55.CrossRefPubMedGoogle Scholar
  15. 15.
    Reynolds N, Sun J, Nagaraja HN, Gifford AL, Wu AW, Chesney MA. Optimizing measurement of self-reported adherence with the ACTG adherence questionnaire: a cross-protocol analysis. JAIDS J Acquir Immune Defic Syndr. 2007;46(4):402–9.CrossRefGoogle Scholar
  16. 16.
    Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000 July 4, 2000;133(1):21–30.Google Scholar
  17. 17.
    Conigliaro J, Gordon AJ, McGinnis KA, Rabeneck L, Justice AC, Study VAC-S. How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? JAIDS J Acquir Immune Defic Syndr. 2003;33(4):521–5.Google Scholar
  18. 18.
    Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Enbal Shacham
    • 1
    Email author
  • Abayomi Agbebi
    • 2
  • Kate Stamm
    • 2
  • E. Turner Overton
    • 2
  1. 1.Health Communication Research Laboratory, The Brown School of Social WorkWashington University in St. LouisSt. LouisUSA
  2. 2.Department of Medicine, Division of Infectious DiseasesWashington University School of MedicineSt. LouisUSA

Personalised recommendations